DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sarepta Therapeutics
Sarepta Therapeutics
NASDAQ Stock Market
Guidelines with Regard to the Composition, Calculation and Management of the Index
SAREPTA THERAPEUTICS, INC. (Exact Name of Registrant As Specified in Its Charter)
05/09/2016 Provider Subsystem Healthcare and Family Services Run Time: 04:25:50 Report Id 2794D052 Page: 01
Rebateable Manufacturers
Cme Information for the Clinical Care Session Only
The Bottom 99
Rare Diseases Whitepaper
MDA2020 Mitelman Sarepta Study 405 FINAL.Pdf
MANUFACTURERS with CMS AGREEMENTS AS of 5-14-21 Labeler Code Labeler Name Program End Date 00002 ELI LILLY and COMPANY 00003 E.R
Sarepta, FDA and the Dangers of Strong Early Results
Sarepta Therapeutics, Inc. Annual Report 2016
Drug Information Center Highlights of FDA Activities – 2/1/21 – 2/28/21
Sarepta Therapeutics, Inc. (Exact Name of Registrant As Specified in Its Charter)
A Sample of Attendees from the Last Two Years… TITLE COMPANY VP
Gene Therapy for Duchenne Muscular Dystrophy
Orphans Should Live Alone
Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts
Top View
Antibody Testing and Gene Therapy
08/06/2016 Provider Subsystem Healthcare and Family Services Run Time: 00:10:55 Report Id 2794D052 Page: 01
The Bottom 99
Sarepta Therapeutics, Inc. (Nasdaqgs: SRPT) Updating Coverage
Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial Craig Mcdonald,1 Perry Shieh,2 Hoda Z
Customer Rebate List Covering
KEI Note Pharmaceutical Company R&D Cost Disclosures in SEC Filings
2020 Medicines in Development for Children
Full Report PDF, 2.6 MB
Rare Disease FEB14.Indd
United States Securities and Exchange Commission Washington, D.C
I, Virginie Hivert
Spark Therapeutics CEO and Former Merck President to Keynote Veeva
Disclosure Index
Manufacturer's W/Start/End Dates and Sc Ind Appendix 1
Document Nda 206488
Fu N D C O M M En Ta
Rebateable Manufacturers
What to Watch for in Biotech in 2018
The Top 100 June 1, 2013 a List of Stocks Topping Our Custom 'Torpedo’ Screen